Results 71 to 80 of about 15,000 (182)

Preparation and Evaluation of Recombinant Human Erythropoietin Loaded Tween 80-Albumin Nanoparticle for Traumatic Brain Injury Treatment

International Journal of Nanomedicine, 2020
Yuanfeng Xue,1,* Junhong Ding,1,* Yulong Liu,2 Yuchun Pan,1 Penglai Zhao,3 Zhiwen Ren,1 Jian Xu,1 Liangliang Ye,1 Ying Xu2 1Department of Neurosurgery, Nanjing Lishui People’s Hospital, Zhongda Hospital Lishui Branch Southeast University, Nanjing ...
Xue Y, Ding J, Liu Y, Pan Y, Zhao P, Ren Z, Xu J, Ye L, Xu Y   +8 more
doaj  

Recombinant human erythropoietin corrects anemia in a feline model of chronic kidney disease

Open Veterinary Journal
Background: Anemia is a common systemic complication of chronic kidney disease (CKD) in cats, arising mainly from insufficient endogenous erythropoietin synthesis and impaired iron utilization.
Mykola Zhelavskyi, Mykola Maryniuk, Serhii Kernychnyi, Maryna Drobot, Lesia Klymkovetska, Ruslan Kolinchuk   +5 more
doaj   +1 more source

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients. [PDF]

Drug Res (Stuttg), 2023
Dwitanto K, Angginy N, Sutandar W.
europepmc   +1 more source

Effects of Recombinant Human Erythropoietin (rHuEpo) on the Blood Cells and Hematopoiesis in Spleen of Rats [PDF]

Journal of Sciences, Islamic Republic of Iran, 2004
Recombinant human erythropoietin is a glycoprotein hormone that stimulates erythropoiesis. In clonogenic assays of hematopoietic progenitors, high concen-trations of erythropoietin (Epo) increase CFU-E and diminish the number of granulocytes formed per ...
doaj  

Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG–PLA micelle

International Journal of Nanomedicine, 2012
Yanan Shi,1,2,* Wan Huang,1,* Rongcai Liang,1–3 Kaoxiang Sun,2,3 Fangxi Zhang,2,3 Wanhui Liu,2,3 Youxin Li1–31College of Life Science, Jilin University, Changchun, China; 2State Key Laboratory of Long-acting and Targeting Drug ...
Shi YN, Huang W, Liang RC, Sun KX, Zhang FX, Liu WH, Li YX   +6 more
doaj  

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study. [PDF]

Clin Appl Thromb Hemost, 2023
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Vishwakarma R, AlFaifi M, Alsohimi S, Alrayes A, Albishi S, Alqahtani R, Alalawi M, Al Sulaihim I, Alanazi TA, Alqahtani RA, Almagthali A, Jomah S, Alshlowi A, Alshammari TR, Alzahrani SS, Abdulqader MI.   +19 more
europepmc   +1 more source

Recombinant human erythropoietin plus methylprednisolone versus methylprednisolone in treatment of acute spinal cord injury：protocol for a systematic review and meta-analysis. [PDF]

BMJ Open, 2022
Fang M, Zhou J, Huang S, Zhang Y, He Y, Zeng Y, Song Y.   +6 more
europepmc   +1 more source

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis. [PDF]

Front Med (Lausanne), 2023
Cheng S, Zhou T, Yu L, Zhang Z, Chen Y, Zhang M, Cui J, Yu W, Zhou J, Yu Y.   +9 more
europepmc   +1 more source

Transcriptomic Markers of Recombinant Human Erythropoietin Micro-Dosing in Thoroughbred Horses. [PDF]

Genes (Basel), 2021
Dahlgren AR, Knych HK, Arthur RM, Durbin-Johnson BP, Finno CJ.   +4 more
europepmc   +1 more source

Serum Erythropoietin Levels in Pediatric Hematologic Disorders and Impact of Recombinant Human Erythropoietin Use

Turkish Journal of Hematology, 2009
Objective: In anemic patients, the correlation between serum erythropoietin (sEpo) level and the severity of anemia has been reported previously. However, in different anemia groups, different sEpo levels are measured in patients with similar hemoglobin
Mualla Çetin, Şule Ünal, Fatma Gümrük, Aytemiz Gürgey, Çiğdem Altay   +4 more
doaj